BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 22416010)

  • 1. Regulation of the activins-follistatins-inhibins axis by energy status: Impact on reproductive function.
    Perakakis N; Upadhyay J; Ghaly W; Chen J; Chrysafi P; Anastasilakis AD; Mantzoros CS
    Metabolism; 2018 Aug; 85():240-249. PubMed ID: 29752954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activin A and Follistatin Serum Concentrations in Breast Augmentation Patients.
    Zeplin PH
    Plast Surg (Oakv); 2023 Nov; 31(4):377-382. PubMed ID: 37915344
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of Serum Arginase-1 Concentrations and Serum Arginase Activity for the Non-Invasive Diagnosis of Endometriosis.
    Pliszkiewicz M; Czystowska-Kuzmicz M; Soroczynska K; Siekierski BP; Safranow K
    J Clin Med; 2024 Mar; 13(5):. PubMed ID: 38592313
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of oxidative stress in endometriosis: A case-control study.
    Alizadeh M; Mahjoub S; Esmaelzadeh S; Hajian K; Basirat Z; Ghasemi M
    Caspian J Intern Med; 2015; 6(1):25-9. PubMed ID: 26221493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immunoreactive activin A levels in normal subjects and patients with various diseases.
    Harada K; Shintani Y; Sakamoto Y; Wakatsuki M; Shitsukawa K; Saito S
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2125-30. PubMed ID: 8964839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review.
    Brulport A; Bourdon M; Vaiman D; Drouet C; Pocate-Cheriet K; Bouzid K; Marcellin L; Santulli P; Abo C; Jeljeli M; Chouzenoux S; Chapron C; Batteux F; Berthelot C; Doridot L
    Reprod Biol Endocrinol; 2024 Feb; 22(1):21. PubMed ID: 38341605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel diagnostic options for endometriosis - Based on the glycome and microbiome.
    Kovács Z; Glover L; Reidy F; MacSharry J; Saldova R
    J Adv Res; 2021 Nov; 33():167-181. PubMed ID: 34603787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal treatments for endometriosis: The endocrine background.
    Vannuccini S; Clemenza S; Rossi M; Petraglia F
    Rev Endocr Metab Disord; 2022 Jun; 23(3):333-355. PubMed ID: 34405378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometriosis and polycystic ovary syndrome are diametric disorders.
    Dinsdale NL; Crespi BJ
    Evol Appl; 2021 Jul; 14(7):1693-1715. PubMed ID: 34295358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis.
    Kimber-Trojnar Ż; Pilszyk A; Niebrzydowska M; Pilszyk Z; Ruszała M; Leszczyńska-Gorzelak B
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34201813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for the Noninvasive Diagnosis of Endometriosis: State of the Art and Future Perspectives.
    Anastasiu CV; Moga MA; Elena Neculau A; Bălan A; Scârneciu I; Dragomir RM; Dull AM; Chicea LM
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activin A Stimulates Aromatase via the ALK4-Smad Pathway in Endometriosis.
    Zheng J; Qu J; Lu P; Hou Z; Cui Y; Mao Y; Qi X; Ji H; Liu J
    Biomed Res Int; 2016; 2016():5791510. PubMed ID: 27833918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research Priorities for Endometriosis.
    Rogers PA; Adamson GD; Al-Jefout M; Becker CM; D'Hooghe TM; Dunselman GA; Fazleabas A; Giudice LC; Horne AW; Hull ML; Hummelshoj L; Missmer SA; Montgomery GW; Stratton P; Taylor RN; Rombauts L; Saunders PT; Vincent K; Zondervan KT;
    Reprod Sci; 2017 Feb; 24(2):202-226. PubMed ID: 27368878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood biomarkers for the non-invasive diagnosis of endometriosis.
    Nisenblat V; Bossuyt PM; Shaikh R; Farquhar C; Jordan V; Scheffers CS; Mol BW; Johnson N; Hull ML
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD012179. PubMed ID: 27132058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Biomarkers for the Detection of Endometriosis.
    Fassbender A; Burney RO; O DF; D'Hooghe T; Giudice L
    Biomed Res Int; 2015; 2015():130854. PubMed ID: 26240814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma miR-17-5p, miR-20a and miR-22 are down-regulated in women with endometriosis.
    Jia SZ; Yang Y; Lang J; Sun P; Leng J
    Hum Reprod; 2013 Feb; 28(2):322-30. PubMed ID: 23203215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of serum activin A and follistatin levels in women with peritoneal, ovarian and deep infiltrating endometriosis.
    Reis FM; Luisi S; Abrão MS; Rocha AL; Viganò P; Rezende CP; Florio P; Petraglia F
    Hum Reprod; 2012 May; 27(5):1445-50. PubMed ID: 22416010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum follistatin levels in women with ovarian endometriosis.
    Florio P; Reis FM; Torres PB; Calonaci F; Abrao MS; Nascimento LL; Franchini M; Cianferoni L; Petraglia F
    Hum Reprod; 2009 Oct; 24(10):2600-6. PubMed ID: 19549703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin A and follistatin in menstrual blood: low concentrations in women with dysfunctional uterine bleeding.
    Reis FM; Nascimento LL; Tsigkou A; Ferreira MC; Luisi S; Petraglia F
    Reprod Sci; 2007 May; 14(4):383-9. PubMed ID: 17644811
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.